Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2012
05/02/2012CN102432682A Preparation method for rat-derived polyclonal antibody of thermoduric bacteria
05/02/2012CN102432673A Brucella bp26 protein epitope, monoclonal antibody and application thereof
05/02/2012CN101928700B Protein kinase PFTK1 monoclonal antibody and preparation method thereof
05/02/2012CN101892240B Japanese blood fluke beta-catenin gene, protein and application
05/02/2012CN101676300B Antibody for inhibitting growth of colorectal carcinoma and its use in preparation of diagnostic agent of Colorectal cancer, endometrial carcinoma and pancreatic cancer
05/02/2012CN101550188B H5 subtype bird-flue virus H5N1 hemagglutinin monoclonal antibody and nucleic acid sequence and preparation method thereof
05/02/2012CN101365723B Antibodies directed to her-3 and uses thereof
05/02/2012CN101328473B Cultures of E1-immortalized cells and processes for culturing the same to increase product yields therefrom
05/02/2012CN101270160B Monoclone antibody 1F1, uses thereof and hybridoma cell line BCSP31-1F1 excreting the antibody
05/01/2012US8168762 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
05/01/2012US8168761 Antibody to SOST peptides
05/01/2012US8168760 Crystalline anti-human IL-12 antibodies
05/01/2012US8168759 Compositions monovalent for CD28 binding and methods of use
05/01/2012US8168757 PD-1 binding proteins
05/01/2012US8168755 Antibodies specific to heterodimers of Bcl-2 family and uses thereof
05/01/2012US8168601 contacting the specific cells with a fusion protein-double stranded RNA complex for treating cancer, viral diseases; specifically binds to a site on a target cell; drug screening
05/01/2012US8168585 Purification of peptides from colostrum
05/01/2012US8168427 Monoclonal antibodies against claudin-18 for treatment of cancer
05/01/2012US8168410 Anti-IGF-IR antibodies and uses thereof
05/01/2012US8168409 Compositions and methods relating to anti-IGF-1 receptor antibodies
05/01/2012US8168397 Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody
05/01/2012US8168394 GAG protein immunoglobulin fusion for use in detection of hepatitis C virus and human immunodeficiency viral infection
05/01/2012US8168207 Immunogenic proteins of leptospira
05/01/2012US8168205 Streptococcus pneumoniae polypeptides
05/01/2012US8168204 PheP, an amino acid permease of Staphylococcus aureus
05/01/2012US8168193 Molecules, compositions, methods and kits for applications associated with flaviviruses
05/01/2012US8168188 Antibody and utilization of the same
05/01/2012US8168187 Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer
05/01/2012US8168186 Therapeutic using a bispecific antibody
05/01/2012US8168183 Antibodies to granulocyte-macrophage colony-stimulating factor
05/01/2012US8168182 Method for treating erectile dysfunction
05/01/2012US8168180 Methods and compositions for modulating angiogenesis
05/01/2012US8168168 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
05/01/2012CA2583910C Angiopoietin-2 specific binding agents
05/01/2012CA2552639C A process for the purification of antibodies
05/01/2012CA2516455C Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
05/01/2012CA2468583C Self-assembling multimeric binding complexes derived from ab5 toxin family members
05/01/2012CA2438080C Gonococcal proteins and nucleic acids
05/01/2012CA2400559C Humanized antibodies that sequester .alpha..beta. peptide
05/01/2012CA2365555C Genetically modified plants having modulated brassinosteroid signaling
05/01/2012CA2335318C Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction
05/01/2012CA2333466C Gbs toxin receptor
05/01/2012CA2322763C Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial uc panca antigens
05/01/2012CA2281620C Neurturin receptor
05/01/2012CA2169524C Dna sequence coding for an a.thaliana protein with delta-5,7 sterol, delta-7 reductase, delta-7-red protein activity, process for producing the same, transformed yeast strains, uses
04/2012
04/26/2012WO2012054745A1 Influenza hemagglutinin-specific monoclonal antibodies for preventing and treating influenza virus infection
04/26/2012WO2012054580A2 Polyvalent chimeric ospc vaccinogen and diagnostic antigen
04/26/2012WO2012054502A1 Identification of antibodies specific for lyssaviruses and methods of their use
04/26/2012WO2012054438A1 Anti-pcsk9
04/26/2012WO2012053828A2 Human interleukin-1 receptor antagonist - hybrid fc fusion protein
04/26/2012WO2012052898A1 Lipid vectors delivering gene silencers
04/26/2012WO2012052230A1 Erbb3 binding antibody
04/26/2012WO2012051734A1 Stable and soluble antibodies
04/26/2012WO2012030057A3 Medium composition for culturing self-activated lymphocytes and method for culturing self-activated lymphocytes using same
04/26/2012WO2012028958A3 Antibody for colorectal cancer marker
04/26/2012WO2012023051A3 Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
04/26/2012WO2012022703A3 Improved anti-serum albumin binding variants
04/26/2012WO2012014078A3 Method of treatment of organic diseases of nervous system, psychoorganic syndrome and encephalopathy
04/26/2012WO2012011955A3 Compositions and methods for production and screening of monoclonal antibodies
04/26/2012WO2012010978A3 A method of treating alzheimer's disease
04/26/2012WO2012010973A3 Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
04/26/2012WO2012010970A3 A method of treating attention deficit hyperactivity disorder
04/26/2012WO2012007839A3 Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
04/26/2012WO2012002745A3 Factor viia complex using an immunoglobulin fragment
04/26/2012WO2011149909A3 Class i mhc phosphopeptides for cancer immunotherapy and diagnosis
04/26/2012US20120102588 Rice zinc finger protein transcription factor dst and use thereof for regulating drought and salt tolerance
04/26/2012US20120102582 Mouse models
04/26/2012US20120101262 Protein purification by caprylic acid (octanoic acid) precipitation
04/26/2012US20120101261 Use of multi-kinase inhibitors in the treatment of vascular hyperpermeability
04/26/2012US20120101260 Sustained drug delivery system
04/26/2012US20120100635 Risk assessment for antibotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin
04/26/2012US20120100632 Monoclonal antibodies to human immunodeficiency virus and uses thereof
04/26/2012US20120100575 Antibodies having altered effector function and methods for making the same
04/26/2012US20120100508 Interactive dental restorative network
04/26/2012US20120100168 Cyclovirus and methods of use
04/26/2012US20120100161 Amatoxin-Armed Therapeutic Cell Surface Binding Components Designed for Tumour Therapy
04/26/2012US20120100159 Anti-tat226 antibodies and immunoconjugates
04/26/2012US20120100158 Anti ceacam1 antibodies and methods of using same
04/26/2012US20120100156 Therapeutic Agent
04/26/2012US20120100155 Pharmaceutical agent
04/26/2012US20120100153 Stable and soluble antibodies
04/26/2012US20120100152 Anti-human cd52 immunoglobulins
04/26/2012US20120100151 Antibodies or Fragments Thereof Directed Against a Staphylococcus Aureus Epitope of ISAA or ISAB
04/26/2012US20120100150 Influenza Hemagglutinin-Specific Monoclonal Antibodies for Preventing and Treating Influenza Virus Infection
04/26/2012US20120100148 Anti-ferroportin 1 monoclonal antibodies and uses thereof
04/26/2012US20120100147 Novel antibodies and their uses in therapeutic and diagnostic methods
04/26/2012US20120100146 Nucleotide and amino acid sequences relating to respiratory diseases and obesity
04/26/2012US20120100144 Biomarker and Treatment for Cancer
04/26/2012US20120100143 Immunogenic proteins from genome-derived outer membrane of leptospira and compositions and methods based thereon
04/26/2012US20120100142 Monoclonal antibodies to influenza h1n1 virus uses thereof
04/26/2012US20120100141 Drug fusions and conjugates
04/26/2012US20120100140 Stabilized fc polypeptides with reduced effector function and methods of use
04/26/2012US20120100133 Use of anti-cd20 antibody for treating primary intraocular lymphoma
04/26/2012US20120100132 Humanized anti-human tumor necrosis factor alpha monoclonal antibody and sequence thereof
04/26/2012US20120100130 Novel Receptor Hetero-Dimers/-Oligomers
04/26/2012US20120100129 N-Terminal Truncated Protofibrils/Oligomers for Use in Therapeutic and Diagnostic Methods for Alzheimer's Disease and Related Disorders
04/26/2012US20120100074 Humanized antibodies against light and uses thereof
04/26/2012CA2815342A1 Methods for processing inclusion bodies
04/26/2012CA2815279A1 Polyvalent chimeric ospc vaccinogen and diagnostic antigen
04/26/2012CA2815080A1 Anti-folate receptor alpha antibody glycoforms
1 ... 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 ... 1494